Stock A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 24/06/2024 am IST 		5-day change 1st Jan Change
95,800 KRW +1.27% Intraday chart for Chong Kun Dang Pharmaceutical Corp. -6.17% -26.81%
25/04 Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024. CI
23/01 Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. CI

Chart calendar Chong Kun Dang Pharmaceutical Corp.

1d1250f8e.qKkcsSOiNLF6h9hxLq9XphbHsogWSIuwHvx9D0uMF9o.wOJ32VnocfYuvrc-Qug0kFOo-b4uC_nhao5FZiS8Iu3_nlXfENZZ9i3Muw~bdf61e7d37502e476fd43c6227467905

Upcoming events on Chong Kun Dang Pharmaceutical Corp.

13/08/2024 Q2 2024 Earnings Release (Projected)
07/04/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)
18/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Chong Kun Dang Pharmaceutical Corp.

16/05/2024 Q1 2024 Earnings Release
20/03/2024 Q4 2023 Earnings Release
15/05/2023 Q1 2023 Earnings Release
14/03/2023 Q4 2022 Earnings Release
16/08/2022 Interim 2022 Earnings Release
16/05/2022 Q1 2022 Earnings Release
17/08/2021 Interim 2021 Earnings Release
17/05/2021 Q1 2021 Earnings Release
08/02/2021 FY 2020 Earnings Release
30/03/2020 FY 2019 Earnings Release
14/11/2019 Q3 2019 Earnings Release
15/05/2019 Q1 2019 Earnings Release
26/07/2018 Interim 2018 Earnings Release
24/04/2017 Q1 2017 Earnings Release

Past dividends on Chong Kun Dang Pharmaceutical Corp.

27/12/2023 Annual 1100 KRW
28/12/2022 Annual 1000 KRW
29/12/2021 Annual 1000 KRW
29/12/2020 Annual 1000 KRW
27/12/2019 Annual 900 KRW
27/12/2018 Annual 900 KRW
27/12/2017 Annual 900 KRW
28/12/2016 Annual 900 KRW
29/12/2015 Annual 600 KRW
29/12/2014 Annual 800 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		1 079
1 070
0.85%		1 301
1 310
-0.72%		1 334
1 337
-0.24%		1 472
1 463
0.61%		1 650
1 633
1.01%
1 541

EBITDA
Billions KRW		Released
Forecast
Spread 		94,8
95,2
-0.5%		145
161
-9.83%		119
137
-12.77%		138
141
-2.37%		276
260
6.29%
149

EBIT
Billions KRW		Released
Forecast
Spread 		77,0
74,5
3.42%		127
139
-8.61%		94,1
113
-16.67%		107
111
-3.93%		241
226
6.53%
115

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		72,7
70,7
2.9%		120
134
-10.43%		77,4
95,2
-18.7%		101
108
-6.21%		237
229
3.26%
118

Net income
Billions KRW		Released
Forecast
Spread 		53,9
50,3
7.04%		88,7
100
-11.61%		39,4
53,4
-26.14%		82,9
85,2
-2.63%		209
201
4.03%
96,2

EPS
KRW		Released
Forecast
Spread 		4 300
3 800
13.17%		7 082
7 579
-6.56%		3 168
4 098
-22.68%		6 771
6 443
5.1%		16 416
15 391
6.66%
7 156

Announcement Date31/01/2008/02/2110/02/2203/02/2305/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Billions KRW		Released
Forecast
Spread 		338
335
0.95%		365
352
3.73%		381
371
2.6%		389
379
2.49%		360
357
0.88%		392
378
3.63%		396
397
-0.26%		501
504
-0.49%		353
355
-0.47%
388


397


388


391


415

EBITDA
Billions KRW		Released
Forecast
Spread




















123
121
1.67%		36,0
33,8
6.71%
42,8


44,0


28,5


40,1


46,4

EBIT
Billions KRW		Released
Forecast
Spread 		24,3
22,7
7.41%		28,1
26,1
7.75%		39,7
35,8
10.78%		15,0
18,2
-17.31%		30,1
29,0
3.66%		43,4
34,0
27.72%		53,1
48,1
10.34%		114
116
-1.69%		26,8
25,4
5.26%
32,4


34,3


21,8


31,0


38,6

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		23,6
17,0
38.88%		26,0
20,8
25.37%		37,7
35,9
4.98%		13,6
21,6
-37.11%		30,3
28,0
8.24%		43,3
33,3
29.89%		52,6
45,9
14.65%		111
115
-4.05%		31,8
25,3
25.51%
29,3


33,1


21,2


28,0


39,0

Net income
Billions KRW		Released
Forecast
Spread 		17,2
15,8
8.78%		24,5
17,2
42.18%		29,2
24,8
17.94%		12,1
12,7
-4.6%		34,9
22,0
58.58%		41,8
25,9
61.67%		43,5
39,3
10.86%		88,6
93,4
-5.09%		25,1
21,0
19.37%
30,0


31,0


11,0


22,0


31,0

Announcement Date29/04/2229/07/2228/10/2203/02/2315/05/2328/07/2327/10/2305/02/2426/04/24-----

Upcoming sector events for Chong Kun Dang Pharmaceutical Corp.

18/07/2024 11:45 am KRKA, D. D.: Q2 2024 Earnings Release
23/07/2024 SANOFI INDIA LIMITED: Q2 2025 Earnings Release (Projected)
25/07/2024 AJANTA PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
26/07/2024 BORYUNG CORPORATION: Q2 2024 Earnings Release (Projected)
29/07/2024 ONO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
30/07/2024 SANOFI INDIA LIMITED: Q2 2024 Earnings Release (Projected)
31/07/2024 STRIDES PHARMA SCIENCE LIMITED: Q1 2025 Earnings Release (Projected)
02/08/2024 SUN PHARMACEUTICAL INDUSTRIES LTD.: Q1 2025 Earnings Release (Projected)
06/08/2024 GEDEON RICHTER: Q2 2024 Earnings Release
07/08/2024 ASTRA INDUSTRIAL GROUP COMPANY: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Chong Kun Dang Pharmaceutical Corp.

28/05/2024 09:23 pm WOCKHARDT LIMITED: Q4 2024 Earnings Release
24/05/2024 08:24 pm GLENMARK PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
22/05/2024 03:05 pm SUN PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
22/05/2024 01:43 pm STRIDES PHARMA SCIENCE LIMITED: Q4 2024 Earnings Release
19/05/2024 12:16 pm MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY: Q1 2024 Earnings Release
17/05/2024 03:40 pm ZYDUS LIFESCIENCES LIMITED: Q4 2024 Earnings Release
16/05/2024 01:55 pm CAPLIN POINT LABORATORIES LIMITED: Q4 2024 Earnings Release
16/05/2024 11:45 am KRKA, D. D.: Q1 2024 Earnings Release
16/05/2024 SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release
16/05/2024 CELLTRION PHARM, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A185750 Stock
  4. Calendar Chong Kun Dang Pharmaceutical Corp.